Friday, May 29, 2015

UPDATE 1-Bristol's Opdivo cuts risk of lung cancer death for some

… from advanced non-squamous non-small cell lung cancer (NSCLC), compared with chemotherapy. The … Opdivo's performance in lung cancer, the most common form of … era in second-line treatment of lung cancer," said Fouad Namouni, who … as an initial treatment for lung cancer. The trial results showed median …

No comments:

Post a Comment